Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2006
11/16/2006US20060257973 Pseudomycin production by pseudomonas syringae
11/16/2006US20060257959 Glucose dehydrogenase
11/16/2006US20060257953 Artificial antibody polypeptides
11/16/2006US20060257940 Transformed Shigella
11/16/2006US20060257928 ANGE gene in atopy
11/16/2006US20060257924 Process for the isolation of the extrachromosomal DNA and method for the diagnosis based on the electrophoretic analysis of such DNA
11/16/2006US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006US20060257859 Recombinant enterovirus 71 neutralizing antibodies and applications thereof
11/16/2006US20060257429 Vaccine for periodontal disease
11/16/2006US20060257421 Pneumolysin derivatives
11/16/2006US20060257418 Vaccine
11/16/2006US20060257414 Mycoplasma gallisepticum formulation
11/16/2006US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/16/2006US20060257387 Sugar chain synthase gene
11/16/2006US20060257384 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
11/16/2006US20060257373 Antifungal formulation containing Streptomyces s.p.p., method for preparing the composition and relevant use
11/16/2006US20060257372 Improvements in ruminants such as increased milk production, feedlot performance, growth rate, decrease in finishing time, lower digestive morbidity and mortality, lower incidence of lactic acidosis
11/16/2006US20060257367 Tumour-cell specific gene expression and its use in cancer therapy
11/16/2006US20060257366 Chimeric glycoproteins and pseudotyped lentiviral vectors
11/16/2006DE102005019302A1 Carrier zum Targeting von Nervenzellen Carrier for targeting neurons
11/15/2006EP1721985A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles
11/15/2006EP1721984A2 Method for cloning and expression of the NheI restriction endonuclease in E. coli
11/15/2006EP1721983A1 Triterpene hydroxylase
11/15/2006EP1721977A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
11/15/2006EP1721976A1 Modified promoter
11/15/2006EP1721973A1 Mutant bacterium belonging to the genus bacillus
11/15/2006EP1721972A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
11/15/2006EP1721966A1 Bacterial strain and composition used to accelerate composting and as a fertilizer
11/15/2006EP1721965A1 Method for the preparation and use of protozoan cultures
11/15/2006EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006EP1721527A2 Lipase and use of same for improving doughs and baked products
11/15/2006EP1720993A1 Method for producing l-threonine using bacteria belonging to the genus escherichia
11/15/2006EP1720977A1 L-glutamic acid-producing microorganism and a method for producing l-glutamic acid
11/15/2006EP1720976A1 Method and device for thermal conditioning of a cell
11/15/2006EP1720975A2 Method for making a liquid concentrate of food-grade acclimated and viable bacteria
11/15/2006EP1720974A1 Frozen lactic acid bacterial culture of individual pellets
11/15/2006EP1720886A1 Macrolides and methods for producing same
11/15/2006EP1720539A2 Schizochytrium fatty acid synthase (fas) and products and methods related thereto
11/15/2006EP1407014B1 Screening method for attenuating or virulence defective microbial cells
11/15/2006EP1387890B1 Peptidylarginine deiminase 6
11/15/2006EP1315824B1 Method for an enzymatic reaction of compounds having at least one nitrile function and/or at least one amide function
11/15/2006EP1283869B1 Novel bee venom polypeptides and methods of use thereof
11/15/2006EP1222281B1 Immunoligically significant herpes simplex virus antigens
11/15/2006EP1208214B1 Genetically engineered bleb vaccine
11/15/2006EP1198560B1 Mammalian adhesion protease
11/15/2006EP1114147B1 A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme
11/15/2006EP1064372B1 Compounds and methods for therapy and diagnosis of lung cancer
11/15/2006EP1054950B1 Hiv chemokines
11/15/2006EP1051502B1 Highly efficient controlled expression of exogenous genes in e. coli
11/15/2006EP1012294B1 Microbial genes for secreted beta-glucuronidases, gene products and uses thereof
11/15/2006CN1863921A Methods for expression and purification of immunotoxins
11/15/2006CN1861795A Product and process for transformation of thraustochytriales microorganisms
11/15/2006CN1861790A Preparation process of human recombined parathyroid hormone 1 84
11/15/2006CN1861785A Pseudomonas putida capable of resisting organic solvent and application in dual liquid phase reaction
11/15/2006CN1861784A Preparation process of concentrating photosynthetic bacteria
11/15/2006CN1861783A Inserting tube detecting method of soil and fresh water nematode and plant nematode
11/15/2006CN1861782A Artificial cultivating method of enriched selenium Cordyceps militaris and application of fruiting body
11/15/2006CN1861781A Picking method of single cell algae
11/15/2006CN1861780A Microorganism keeping living process
11/15/2006CN1861199A Biological deodorization and purification agent, and its use
11/15/2006CN1284858C Method for producing L-phosphinothricine by enzymatic transamination with aspartate
11/15/2006CN1284850C Method for the recombinant production of polypeptides
11/15/2006CN1284471C Active biological fodder additive
11/14/2006US7135623 Nucleic acid(s) obtained from tetrahymena and which code(s) for a ciliate-specific delta-6-desaturase involved in biosynthesis of polyunsaturated fatty acids; hybridization; transgenic organisms; gene expression
11/14/2006US7135612 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
11/14/2006US7135605 Metal binding proteins and associated methods
11/14/2006US7135560 Vectors; cells; drug targets
11/14/2006US7135559 Proteins and novel genes encoding the same
11/14/2006US7135552 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
11/14/2006US7135551 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of glandular disorders
11/14/2006US7135453 Reagents and methods for smooth muscle therapies
11/14/2006US7135334 Stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more
11/14/2006US7135327 Yeast cell bodies containing high concentrations of nucleic acid for use in drug design and flavor enhancement of foods; alcoholic beverages
11/14/2006US7135326 UDP-glucosyltransferases
11/14/2006US7135323 Microbially expressed thermotolerant phytase for animal feed
11/14/2006US7135321 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents
11/14/2006US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006US7135318 Modified reductase and its gene
11/14/2006US7135316 Escherichia coli having accession No. PTA 1579 and its use to produce polyhydroxybutyrate
11/14/2006US7135315 Aldehyde dehydrogenase gene
11/14/2006US7135313 Using modified grampositive bacteria as bioreactors for fermentation of lysine; for use in medicine, cosmetics and animal feeds
11/14/2006US7135309 Processes for the bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism
11/14/2006US7135308 Harvesting starch-accumulating filament-forming or colony-forming algae to form a biomass, initiating cellular decay, fermenting in the presence of yeast, isolating the ethanol; collecting carbon dioxide, heat or biodiesel starting materials; industrial scale
11/14/2006US7135188 Methods and compositions for immunotherapy of cancer
11/14/2006US7135182 Administration of substrates for transglutaminases or antibodies against such substrates; identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans
11/14/2006US7135181 Method for down-regulation of amyloid
11/14/2006US7135176 VMP-like sequences of pathogenic Borrelia
11/09/2006WO2006118313A1 Novel polypeptide and use thereof
11/09/2006WO2006118289A1 Method for identification of compound having antidepressant effect
11/09/2006WO2006117910A1 Monoclonal antibody against platelet membrane glycoprotein vi
11/09/2006WO2006117541A1 Devices and processes for analysing individual cells
11/09/2006WO2006116962A2 Method for the fermentative production of l-valine, l-isoleucine or l-lysine using coryneform bacteria with reduced or eliminated alanine aminotransferase activity
11/09/2006WO2006116949A1 A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis
11/09/2006WO2006040471A3 Producing hydrogen by heterologous expression of a type ii nad (p) h dehydrogenase in chlamydomonas
11/09/2006WO2005089429A3 Sfec, a sperm flagellar energy carrier protein
11/09/2006WO2003016479A3 Excitatory glycine receptors and methods
11/09/2006US20060253939 Mobilization of viral genomes from T-DNA using site-specific recombination systems
11/09/2006US20060253928 Optimizing glycan processing in plants
11/09/2006US20060253925 Coleopteran-toxic polypeptide compositions